Haemodynamics of intravenous paracetamol in neonates Karel AllegaertGunnar Naulaers Pharmacodynamics 04 July 2010 Pages: 855 - 858
Discovery of the nonfunctional CYP2D6*31 allele in Spanish, Puerto Rican, and US Hispanic populations Andrea GaedigkMaria Isidoro-GarcíaSusan Corey Pharmacogenetics 16 May 2010 Pages: 859 - 864
Effect of ABCB1 haplotypes on the pharmacokinetics and renin-inhibiting effect of aliskiren Tuija TapaninenPertti J. NeuvonenMikko Niemi Pharmacogenetics 23 May 2010 Pages: 865 - 870
CYP2C19 activity comparison between Swedes and Koreans: effect of genotype, sex, oral contraceptive use, and smoking Margareta RamsjöEleni AklilluLeif Bertilsson Pharmacogenetics 25 May 2010 Pages: 871 - 877
Differential outcomes from metabolic ratios in the identification of CYP2D6 phenotypes–focus on venlafaxine and O-desmethylvenlafaxine Mani KandasamyP. SrinivasSaral Thangam Pharmacokinetics and Disposition 06 May 2010 Pages: 879 - 887
Pharmacokinetics of natural mistletoe lectins after subcutaneous injection Roman HuberJürgen EisenbraunChristoph H. Gleiter Pharmacokinetics and Disposition 14 May 2010 Pages: 889 - 897
Effect of dose timing in relation to food intake on systemic exposure to blonanserin Junji SaruwatariNorio Yasui-FurukoriSunao Kaneko Pharmacokinetics and Disposition 20 May 2010 Pages: 899 - 902
Reversible elevations of serum creatinine levels but no effect on glomerular filtration during treatment with the direct thrombin inhibitor AZD0837 Kajs-Marie SchützerMaria K. SvenssonKarin Wåhlander Pharmacokinetics and Disposition 10 June 2010 Pages: 903 - 910
Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-up Pål GjerdenLars SlørdalJørgen G. Bramness Pharmacoepidemiology and Prescription 03 June 2010 Pages: 911 - 917
Off-label antibiotic use in children in three European countries Alessandro PortaSusanna EspositoNicola Principi Pharmacoepidemiology and Prescription 08 June 2010 Pages: 919 - 927
Inter-country variations in anti-asthmatic drug prescriptions for children. Systematic review of studies published during the 2000–2009 period Marina BianchiAntonio ClavennaMaurizio Bonati Pharmacoepidemiology and Prescription 09 June 2010 Pages: 929 - 936
Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospital Gloria CerezaAntonia AgustíJosep Maria Arnau Pharmacoepidemiology and Prescription 16 June 2010 Pages: 937 - 945
A signal for an abuse liability for pregabalin—results from the Swedish spontaneous adverse drug reaction reporting system Sofie SchwanAnders SundströmPär Hallberg Pharmacoepidemiology and Prescription 19 June 2010 Pages: 947 - 953
Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as a differentiating factor Wiesław Jerzy CubałaMariusz WigluszMaria Gałuszko-Węgielnik Letter to the Editors Open access 16 June 2010 Pages: 955 - 955
Response to “Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as differentiating factor” Thomas M. PolasekJohn O. Miners Letter to the Editors 16 June 2010 Pages: 957 - 958
Letter to the editor: pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism Cédric MercierLaetitia DahanJoseph Ciccolini Letter to the Editors 19 June 2010 Pages: 959 - 960
